by TractManager | Jan 28, 2021 | News
The Food and Drug Administration (FDA) has announced a recall of 1 lot of cisatracurium besylate injection (Meitheal Pharmaceuticals Inc.) due to mislabeling.The decision to recall the product was made after a product complaint revealed that a portion of cartons...
by TractManager | Jan 25, 2021 | News
SANTA MONICA, CA and HOUSTON, TX – January 25, 2021 —(PRNEWSWIRE)— symplr, a leading global healthcare governance, risk management, and compliance (“GRC”) software-as-a-service (“SaaS”) platform, backed by Clearlake Capital Group, L.P. (together with its affiliates,...
by TractManager | Jan 25, 2021 | Health Technology Assessment
Focus of the Report: Vagus nerve stimulation (VNS) is used as an adjunct to antiepileptic drugs (AEDs) for the treatment of seizures uncontrolled by medical management, epileptic surgery, or other interventions such as ketogenic diets.Technology Description: VNS...
by TractManager | Jan 25, 2021 | Emerging Technology Report
Lupkynis (voclosporin) is an oral calcineurin-inhibitor immunosuppressant indicated in combination with a background immunosuppressive therapy regimen for the treatment of adult patients with active lupus nephritis (LN).If you have a Hayes login, click here to view...
by TractManager | Jan 22, 2021 | News
The Food and Drug Administration (FDA) has approved Cabenuva (cabotegravir and rilpivirine, injectable formulation; ViiV Healthcare) as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults to replace a current...
Recent Comments